About EyePoint, Inc.
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery. pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner. In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.
2BB score and signals
EyePoint, Inc.’s current 2BB score is 45 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 60 | Moderate |
| Momentum | 37 | Weakening |
| Financial strength | 0 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 49 | Moderate |
Company facts
| Headquarters | Watertown, Massachusetts, United States |
| Founded | 2000 |
| Employees | 214 |
| 52-week range | $9.65 – $19.11 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-03 | — | -0.9238 | — | $228,561.00 |
| 2026-08-05 | — | -0.9705 | — | $414,997.00 |
| 2026-05-06 | -0.99 | -0.8136 | $696,000.00 | $359,886.00 |
| 2026-03-04 | -0.81 | -0.7627 | $620,000.00 | $1.03M |
Related companies
